Log in using your username and password
Purchase Short Term Access
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Data supplements
Supplementary Data
- Supplemental Figure 1 - Supplemental Figure 1: Response to immunization is only modestly affected by selinexor.
- Supplemental Figure 2 - Supplemental Figure 2: IFNγ secretion is impaired by selinexor.
- Supplemental Figure 3 - Supplemental Figure 3: Degranulation of effector CD8 T cells is affected by selinexor.
- Supplemental Figure legends - Legends for supplemental figures
March 2017
Volume 16, Issue 3
Volume 16, Issue 3
Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with Immunotherapy
Permalink:
Jump to section
Advertisement